It is very clear that the present system of innovation for medicines is very inefficient and really somewhat corrupt. It benefits shareholders over patients; it produces for the rich markets and not for the poor and does not produce for minority diseases.

John Sulston

John Sulston

Benefits Clear Corrupt Diseases Does Inefficient Innovation Markets Medicines Minority Over Patients Poor Present Produce Produces Really Rich Shareholders Somewhat System Very

Related Quotes

Biomedical research is only as good as its delivery. Distribution of medicines by charities is no more than a stopgap.

— John Sulston

BiomedicalCharitiesDelivery

Our work on C. elegans emphasized the benefits of sharing large amounts of information. We took a global approach to discover the mechanisms that led to the development of the worm.

— John Sulston

AmountApproachBenefits

We would be a lesser place without the H-1Bs, and the benefits to our patients would be lesser in their absence.

— Bruce Larson

BenefitsLesserPatients

One of the Great Rules of Economics According to John Green
If you are rich, you have to be an idiot not to stay rich. And if you are poor, you have to be really smart to get rich.

economicspoorrich

Bioscience and biotech offer many opportunities. The U.S. focuses on the rich man; India has rich man diseases and poor man diseases. So you have a much larger set of opportunities.

— Romesh Wadhwani

DiseasesIndiaLarger